Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in regulatory requirements for developmental toxicology.

C A Kimmel1, S L Makris

  • 1National Center for Environmental Assessment (8623D), Office of Research and Development, US Environmental Protection Agency, Ariel Rios Building, 1200 Pennsylvania Ave, Washington, DC 20460, USA. kimmel.carole@epa.gov

Toxicology Letters
|April 27, 2001
PubMed
Summary

Regulatory changes, like the Food Quality Protection Act (FQPA), are reshaping developmental toxicity testing and risk assessment, with a focus on children's health and neurotoxicity. New guidelines address exposure duration and endpoints to better evaluate risks for vulnerable populations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of the ToxRTool's ability to rate the reliability of toxicological data for human health hazard assessments.

Regulatory toxicology and pharmacology : RTP·2015
Same author

Accounting for susceptibility in risk assessment: current practice and new directions.

Environmental toxicology and pharmacology·2011
Same author

Overview of teratology.

Current protocols in toxicology·2010
Same author

Inter-laboratory control data for reproductive endpoints required in the OPPTS 870.3800/OECD 416 reproduction and fertility test.

Birth defects research. Part B, Developmental and reproductive toxicology·2009
Same author

A qualitative retrospective analysis of positive control data in developmental neurotoxicity studies.

Neurotoxicology and teratology·2004
Same author

Response-surface analysis of exposure-duration relationships: the effects of hyperthermia on embryonic development of the rat in vitro.

Toxicological sciences : an official journal of the Society of Toxicology·2002

Area of Science:

  • Environmental Toxicology
  • Regulatory Science
  • Developmental Biology

Background:

  • Legislative and regulatory shifts over five years necessitate re-evaluating developmental toxicity testing requirements.
  • The Food Quality Protection Act (FQPA) of 1996 mandates rigorous evaluation of children's health risks by the U.S. Environmental Protection Agency (USEPA).
  • Specific FQPA provisions require increased safety factors for children if data are insufficient or if they exhibit greater sensitivity.

Purpose of the Study:

  • To review and update regulatory requirements for developmental toxicity testing and risk assessment in response to new legislation.
  • To incorporate enhanced protocols for evaluating potential neurodevelopmental, reproductive, and immune effects.
  • To ensure children's health risks are adequately addressed in the risk assessment process.

Related Experiment Videos

Main Methods:

  • Review of existing USEPA testing protocols and guidelines for pesticides and toxic substances.
  • Extension of dosing periods in prenatal developmental toxicity studies to term.
  • Addition of specific endpoints to the 2-generation reproduction study to assess neurological, reproductive, and immune alterations.
  • Development of new testing guidelines, including developmental neurotoxicity, immunotoxicity, and endocrine disruptor studies.

Main Results:

  • Revised USEPA testing guidelines were published in 1998, introducing a developmental neurotoxicity testing protocol.
  • A proposed core set of toxicology studies includes developmental neurotoxicity, adult neurotoxicity, and adult immunotoxicity.
  • Recommendations for new guidelines cover developmental immunotoxicity, carcinogenesis, specialized neurotoxicity, endocrine disruption, pharmacokinetics, and neonate dosing.
  • Ongoing review focuses on adequacy of reference values (e.g., chronic RfD, RfC), life stages, endpoints, and exposure durations.

Conclusions:

  • Recent legislative changes, particularly FQPA, have driven significant revisions in developmental toxicity testing and risk assessment policies.
  • The updated guidelines and proposed studies aim to provide a more comprehensive evaluation of potential health risks, especially for children.
  • Continuous evaluation of testing methodologies and reference values is crucial for ensuring robust risk assessment and protection of public health.